Uppsala, Sweden.
Beckman Coulter, Chaska, MN.
Clin Chem. 2018 Mar;64(3):455-464. doi: 10.1373/clinchem.2017.277541. Epub 2018 Jan 18.
A process is described to assess the commutability of a reference material (RM) intended for use as a calibrator, trueness control, or external quality assessment sample based on the difference in bias between an RM and clinical samples (CSs) measured using 2 different measurement procedures (MPs). This difference in bias is compared with a criterion based on a medically relevant difference between an RM and CS results to make a conclusion regarding commutability. When more than 2 MPs are included, the commutability is assessed pairwise for all combinations of 2 MPs. This approach allows the same criterion to be used for all combinations of MPs included in the assessment. The assessment is based on an error model that allows estimation of various random and systematic sources of error, including those from sample-specific effects of interfering substances. An advantage of this approach is that the difference in bias between an RM and the average bias of CSs at the concentration (i.e., amount of substance present or quantity value) of the RM is determined and its uncertainty estimated. An RM is considered fit for purpose for those MPs for which commutability is demonstrated.
描述了一种基于参考物质(RM)和临床样本(CS)测量值之间偏倚差异的方法,以评估 RM 作为校准品、真值控制或外部质量评估样本的适用性。该偏倚差异与基于 RM 和 CS 结果之间与医学相关差异的标准进行比较,以对适用性做出结论。当包括两个以上 MPs 时,将对所有 MPs 的两两组合进行适用性评估。这种方法允许对评估中包含的所有 MPs 组合使用相同的标准。该评估基于一个误差模型,该模型允许对各种随机和系统误差源进行估计,包括来自干扰物质的样本特异性效应的误差源。这种方法的一个优点是,确定 RM 与 RM 浓度(即存在的物质数量或量值)处 CSs 平均偏倚之间的偏差,并估计其不确定性。对于那些证明具有适用性的 MPs,RM 被认为是符合目的的。